Brian Adams Kymera Therapeutics, Inc. (KYMR) insider trading activity
Brian Adams is Chief Legal Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 52,500 shares of KYMR, which is worth approximately $2.28 Million. The most recent transaction as insider was on Sep 03, 2025, when has been sold 52,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
52.5K
n/a
3M change
n/a
12M change
Total Value Held
$2.28 Million
Brian Adams Transaction History
Also insider at
BA
Brian Adams
Chief Legal Officer
Cambridge, MA